Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

Melissa Gilbert Says 'Little House On The Prairie' Reboot At Netflix "Will Do Things We Didn't Get To Do So Easily In '70s" ...

Reports Q4 revenue $9.7B, consensus $9.44B. “2024 was a remarkable year for PMI. We delivered very strong full-year results driven by the ...

Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced its full year and Q4 2024 financial results. Søren ...

Reports Q4 revenue $521M, consensus $518.54M. The company said, “Our solid sales growth in the second half of 2024 mirrors our plans for ...

The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...

Gut bacteria-produced exopolysaccharides (EPS) help regulate metabolism by modulating gut microbiota, promoting SCFA ...

Roche said on Thursday it is targeting a continued increase in adjusted earnings per share (EPS) at a high single-digit ...

Forest Whitaker returns as Bumpy Johnson this spring with the return of the MGM+ drama series 'Godfather of Harlem' ...

Raymond James noted that the company’s initial 2025 EPS guidance was slightly better ... its position in key franchises. Also Read: FDA Approves Johnson & Johnson’s Treatment As First ...

Abbott reported Q4 sales of $11 billion missing the consensus; adjusted EPS was $1.34 ... up from $1.19 a year ago. Also Read: FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...